Clinical features and prognostic factors in Covid-19: A prospective cohort studySanne de Bruin, Aeilko H. Zwinderman, Matthijs C. Brouwer et al.|EBioMedicine|2021Cited by 137
Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritisMaurits C. F. J. de Rotte, Róbert de Jonge|PLoS ONE|2018Cited by 58
Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infectionLihui Guo, Robert Hemke, Brent Appelman et al.|EBioMedicine|2023Cited by 38
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trialEndry H. T. Lim, Rutger Koning, Alexander P. J. Vlaar et al.|Respiratory Research|2022Cited by 18
Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general wardJustin de Brabander, Menno D. de Jong, Erik H.A. Michels et al.|Respiratory Research|2022Cited by 9